To clarify the regulatory effects of PRPF40B in the nervous system, we studied three SH-SY5Y NB cell lines: WT (non-genetically modified) and two PRPF40B-silenced lines, G1 and G2, generated using specific CRISPR/Cas9 guides. The gene discussed is PRPF40B; the disease is neuroblastoma.